MedTrace Logo

Platelet Rich Plasma (PRP) as a Treatment for ACHILLES Tendon Tears

NCT00731068 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2013-10-24

No results posted yet for this study

Summary

To review the influence of patient derived PRGF on the healing process of Achilles tendon after a surgical correction of a complete tear.

Conditions

  • Achilles Tendon Tear

Interventions

BIOLOGICAL

PRGF

injection of 6cc into injured area of tendon

BIOLOGICAL

placebo

injection of 6 cc of saline into injured area

Sponsors & Collaborators

  • Meir Medical Center

    lead OTHER

Principal Investigators

  • Omer Mei Dan, Dr · Meir Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-02-28
Primary Completion
2009-02-28
Completion
2009-03-31

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00731068 on ClinicalTrials.gov